Trial Profile
The Effect of Rotigotine on Memory in Idiopathic Parkinson's Disease without Cognitive Impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 13 Aug 2015 Status changed from recruiting to completed, as reported by United Kingdom Clinical Research Network record.
- 13 Aug 2015 Accrual to date is 100% as reported by United Kingdom Clinical Research Network record.
- 25 Jul 2015 Accrual to date is 17% as reported by United Kingdom Clinical Research Network record.